Literature DB >> 15860701

Topical nonsteroidal anti-inflammatory drugs for corneal abrasions: meta-analysis of randomized trials.

Lisa Anne Calder1, Sowmya Balasubramanian, Dean Fergusson.   

Abstract

OBJECTIVES: To determine the effectiveness of topical nonsteroidal anti-inflammatory drugs (NSAIDs) in traumatic corneal abrasions.
METHODS: This was a systematic literature review and meta-analysis of randomized clinical trials (RCTs). The following databases were searched: MEDLINE (1966-2004), EMBASE (1980-2004), and Cochrane Central Register of Controlled Trials and Database of Systematic Reviews (first quarter 2004). The structured search strategy included a RCT filter and the terms "cornea," "wounds and injuries," "trauma," "corneal diseases," "eye injuries," "anti-inflammatory agents, nonsteroidal" and specific trade names of topical NSAIDs. In addition, four journals in ophthalmology and emergency medicine were hand searched. Two authors independently reviewed citations from the literature searches. To be included, studies had to be RCTs evaluating topical NSAIDs in traumatic corneal abrasions. Trials were included regardless of language or whether they were unpublished or published. Exclusion criteria were corneal ulcers, nonrandomized studies, animal studies, or perioperative setting. Outcomes were pain scale scores at 24 hours and adverse effects. Two independent reviewers assessed four trial quality components: randomization, double blinding, reporting of withdrawals, and concealment of allocation. Weighted mean difference, using a random effects model, was calculated.
RESULTS: Of the 200 citations identified, 11 RCTs met inclusion criteria. Eight trials were identified from the MEDLINE search, two from the EMBASE search, and one from conference proceedings. Seven trials enrolled fewer than 100 patients, and more than half of the studies were conducted in Europe. Five trials reported suitable data for analysis. The overall weighted mean difference for 459 patients was a reduction in pain by 1.30 points (95% confidence interval = -1.56 to -1.03) on the pain scale. Five of the trials met criteria for good quality. Transient stinging was a commonly noted adverse effect.
CONCLUSIONS: Topical NSAIDs are effective analgesics for traumatic corneal abrasions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15860701     DOI: 10.1197/j.aem.2004.10.026

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  7 in total

1.  Ocular surface injury after shoulder surgery in the beach-chair position.

Authors:  Jung Youn Kim; Yong Girl Rhee
Journal:  Int Orthop       Date:  2018-06-26       Impact factor: 3.075

2.  Reliability of the Evidence Addressing Treatment of Corneal Diseases: A Summary of Systematic Reviews.

Authors:  Ian J Saldanha; Kristina B Lindsley; Flora Lum; Kay Dickersin; Tianjing Li
Journal:  JAMA Ophthalmol       Date:  2019-07-01       Impact factor: 7.389

3.  Deterioration of wound healing and intense suppression of MMP-9 mRNA expression after short-term administration of different topical glucocorticoids or NSAIDs in an avian model of corneal lesions.

Authors:  H Mirarab Razi; N Mosleh; T Shomali; N Tavangar; F Namazi
Journal:  Iran J Vet Res       Date:  2021       Impact factor: 1.376

4.  Topical nonsteroidal anti-inflammatory drugs for corneal abrasions in children.

Authors:  Christine H Smith; Ran D Goldman
Journal:  Can Fam Physician       Date:  2012-07       Impact factor: 3.275

5.  Pain care for patients with epidermolysis bullosa: best care practice guidelines.

Authors:  Kenneth R Goldschneider; Julie Good; Emily Harrop; Christina Liossi; Anne Lynch-Jordan; Anna E Martinez; Lynne G Maxwell; Danette Stanko-Lopp
Journal:  BMC Med       Date:  2014-10-09       Impact factor: 8.775

Review 6.  Efficacy of Topical Analgesics in Pain Control for Corneal Abrasions: A Systematic Review.

Authors:  Bryan Thiel; Alexandra Sarau; Daniel Ng
Journal:  Cureus       Date:  2017-03-27

7.  Corneal antinociceptive effect of (-)-α-bisabolol.

Authors:  Gisele Façanha Diógenes Teixeira; Flávio Nogueira da Costa; Adriana Rolim Campos
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.